Jork von Reden
Director/Miembro de la Junta en PROTEO, INC. .
Cargos activos de Jork von Reden
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
PROTEO, INC. | Director/Miembro de la Junta | 15/11/2018 | - |
CFI Innovation GmbH Berlin Unternehmensberatung und Beteiligun
CFI Innovation GmbH Berlin Unternehmensberatung und Beteiligun Miscellaneous Commercial ServicesCommercial Services CFI Innovation GmbH Berlin Unternehmensberatung und Beteiligun provides business consulting and investment services. The private company is based in Berlin, Germany. Jork von Reden has been the CEO of the German company since 2016. | Director Ejecutivo | 01/01/2016 | - |
Wind Energy Trust Sp zoo | Director Ejecutivo | 01/01/2009 | - |
Historial de carrera de Jork von Reden
Formación de Jork von Reden.
Technical University of Berlin | Graduate Degree |
Estadísticas
Internacional
Alemania | 3 |
Estados Unidos | 2 |
Polonia | 2 |
Operativa
Chief Executive Officer | 2 |
Director/Board Member | 1 |
Graduate Degree | 1 |
Sectorial
Health Technology | 2 |
Consumer Services | 2 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Proteo, Inc.
Proteo, Inc. Pharmaceuticals: MajorHealth Technology Proteo, Inc., a clinical stage drug development company, intends to develop, promote, and market pharmaceuticals and other biotech products. The firm focuses on the development of anti-inflammatory treatments for rare diseases. Its proprietary product Elafin, a human protein that naturally occurs in human skin, lungs, and mammary glands. The company's product is intended for the treatment of post-surgery damage to tissue, pulmonary hypertension, serious injuries caused by accidents, cardiac infarction, and other diseases, as well as for the complications resulting from organ transplantation. It has a license and collaboration agreement with ARTES Biotechnology GmbH to produce Elafin by using the sublicensed yeast HANSENULA POLYMORPHA. The company was founded by Oliver Wiedow and Birge Bargmann on December 18, 1992 and is headquartered in Irvine, CA. | Health Technology |
CFI Innovation GmbH Berlin Unternehmensberatung und Beteiligun
CFI Innovation GmbH Berlin Unternehmensberatung und Beteiligun Miscellaneous Commercial ServicesCommercial Services CFI Innovation GmbH Berlin Unternehmensberatung und Beteiligun provides business consulting and investment services. The private company is based in Berlin, Germany. Jork von Reden has been the CEO of the German company since 2016. | Commercial Services |
Wind Energy Trust Sp zoo |
- Bolsa de valores
- Insiders
- Jork von Reden
- Experiencia